Published on 18 Aug 2021 on Benzinga via Yahoo Finance
66 Biggest Movers From Yesterday
Gainers
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.Alfi Inc (NASDAQ: ALF) gained 40.6% to settle at $10.14 after the company said it has begun the national rollout of tablets to rideshare drivers.monday.com Ltd. (NASDAQ: MNDY) shares gained 24.5% to close at $305.00 after the company reported better-than-expected Q2 results. The company also issued Q3 and FY21 sales guidance above analyst estimates.Sesen Bio, Inc. (NASDAQ: SESN) rose 22.8% to settle at $1.51. Sesen Bio shares fell over 42% on Monday after the FDA issued a Complete Response Letter to the company's bladder cancer candidate Vicineum.Biodesix Inc (NASDAQ: BDSX) gained 21.5% to close at $8.02. Biodesix recently reported worse-than-expected Q2 EPS results.Ensysce Biosciences Inc (NASDAQ: ENSC) surged 19% to settle at $3.45. Ensysce Biosciences posted a Q2 net loss of $1 million.Praxis Precision Medicines Inc (NASDAQ: PRAX) gained 18.3% to close at $15.55. The company, on Monday, posted a narrower quarterly loss.Eco Wave Power Global AB (NASDAQ: WAVE) jumped 18.1% to settle at $9.59 after the company entered into a collaboration agreement with the Procurement Administration in the Israeli Ministry of Defense for the Israeli Navy, to examine the feasibility of installing the Eco Wave Power technology in the Bases of the Navy.Omega Therapeutics Inc (NASDAQ: OMGA) gained 17.5% to settle at $22.51. Omega Therapeutics, last month, priced a $125.8 million IPO to take its "epigenomic controllers" into the clinic.Terns Pharmaceuticals Inc (NASDAQ: TERN) surged 17.2% to close at $11.27 after the company posted a narrower quarterly loss.Vivos Therapeutics Inc (NASDAQ: VVOS) gained 16.8% to close at $3.37. Vivos Therapeutics, last week, reported better-than-expected Q2 sales results.Cardiol Therapeutics Inc (NASDAQ: CRDL) gained 16.3% to settle at $3.78.Rani Therapeutics Holdings Inc (NASDAQ: RANI) gained 16.2% to close at $17.98. The company, last month, priced its IPO at $11 per share.Arbutus Biopharma Corp (NASDAQ: ABUS) rose 16.1% to settle at $3.32.X Financial (NYSE: XYF) rose 16.1% to settle at $5.20. The company recently posted a Q2 profit.Pharmacyte Biotech Inc (NASDAQ: PMCB) surged 15.5% to close at $3.42.Bon Natural Life Ltd (NASDAQ: BON) jumped 14.4% to settle at $11.68 as the company reported first-half FY21 revenue growth of 63.6% year-on-year, to $11.7 million.Cytocom Inc (NASDAQ: CBLI) gained 13.5% to close at $3.11. The company, on Monday, posted a quarterly loss.23andMe Holding Co. (NASDAQ: ME) jumped 13.2% to settle at $8.25 after Credit Suisse initiated coverage on the stock with an Outperform rating and announced a $13 price target.Danimer Scientific, Inc. (NASDAQ: DNMR) climbed 13% to close at $15.02 after the company posted upbeat quarterly results.Forte Biosciences, Inc. (NASDAQ: FBRX) shares gained 12.2% to close at $26.71. Forte Biosciences is expected to review the Q2 results and announce topline data from its Phase 2 clinical trial of FB-401 for the treatment of atopic dermatitis on September 7, 2021.DouYu International Holdings Ltd (NASDAQ: DOYU) gained 11.4% to settle at $3.42. DouYu International recently reported a second-quarter FY21 revenue decline of 6.8% to $361.9 million year-on-year.LM Funding America, Inc. (NASDAQ: LMFA) gained 10.7% to close at $5.09 after the company swung to a profit in the second quarter.BIT Mining Ltd – ADR (NYSE: BTCM) rose 6.9% to close at $6.83 after reporting a lower Q2 loss.Sea Ltd (NYSE: SE) gained 6.1% to close at $308.27 after the company reported better-than-expected Q2 sales results and issued FY21 e-Commerce sales guidance.AiHuiShou International Co Ltd (NYSE: RERE) rose 5.5% to close at $11.61 after the company reported better-than-expected Q2 sales results.